The stock market sank slightly on Friday, with all three major market benchmarks giving up a small amount of ground from Thursday’s close. Slow GDP growth got the bulk of the blame from Wall Street, but it’s also common for market participants to take some money off the table going into the weekend after a strong week.
Meanwhile, earnings season continued to play out, and although the technology industry saw some extremely encouraging reports, not all stocks participated in the rally. Athenahealth (NASDAQ:ATHN), Synchrony Financial (NYSE:SYF), and Time (NYSE:TIME) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.
Athenahealth gets a little sick
Shares of Athenahealth plunged 20% after the company reported discouraging results in its first-quarter financial report. The provider of cloud-based medical records said that sales were up 11% from the year-ago quarter, but the company posted a net loss, and even after adjusting for extraordinary items, Athenahealth saw its bottom line give up ground from the first quarter of 2016. Yet even though management remains optimistic about long-term business prospects for the company, CFO Karl Stubelis noted that sales were below expectations, and Athenahealth chose to revise its full-year outlook for both revenue and earnings downward. With investors having gotten used to lightning-fast growth from the medical records provider, Athenahealth will have to find ways to speed back up if it wants to satisfy its shareholders going forward.
Best Medical Stocks To Own Right Now: Attunity Ltd.(ATTU)
Advisors’ Opinion:
- [By Logan Wallace]
Get a free copy of the Zacks research report on Attunity (ATTU)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Best Medical Stocks To Own Right Now: Hot Tech Stocks To Own For 20()
Advisors’ Opinion:
- [By Max Byerly]
(CURRENCY:) traded flat against the US dollar during the 24 hour period ending at 8:00 AM E.T. on April 18th. In the last seven days, has traded flat against the US dollar. One coin can currently be purchased for about $0.0000 or 0.00000000 BTC on exchanges including 295
- [By Stephan Byrd]
These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:
Get CBRE Group alerts:
Parmer Innovation Center to become mammoth employment hub in Northeast Austin (bizjournals.com) Rockefeller leases 138,000 s/f to Blank Rome (rew-online.com) CBRE Group CEO expects another year of double-digit earnings growth (smartbrief.com) Contrasting CBRE Group (CBRE) and Colliers International Gr (CIGI) (americanbankingnews.com) Scanning the CBRE Group, Inc. (:CBRE) Charts What’s Next For the Shares? (derbynewsjournal.com)
CBRE Group remained flat at $$47.42 during trading on Thursday, according to Marketbeat Ratings. The company’s stock had a trading volume of 1,305,500 shares, compared to its average volume of 2,132,441. The company has a market cap of $15.94 billion, a PE ratio of 17.50, a price-to-earnings-growth ratio of 1.16 and a beta of 1.70. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.18 and a quick ratio of 1.18. CBRE Group has a 12-month low of $46.79 and a 12-month high of $47.41.
- [By ]
For example, say Remind my wife about the party and say don’t forget to pick up a bottle of red wine tonight. Siri will know who your spouse is (or will ask you once) and place that in the To: field, and because you said about the party, Siri knows you want that in the Subject (Re:) field. You also said and say, which places words you said after that into the body of the email. This will all save you time!
Best Medical Stocks To Own Right Now: Luby's, Inc.(LUB)
Advisors’ Opinion:
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Losers
Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent - [By Max Byerly]
Headlines about Luby’s (NYSE:LUB) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Luby’s earned a news impact score of 0.10 on Accern’s scale. Accern also gave news coverage about the restaurant operator an impact score of 47.2262144037183 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Best Medical Stocks To Own Right Now: STAAR Surgical Company(STAA)
Advisors’ Opinion:
- [By Lisa Levin]
STAAR Surgical Company (NASDAQ: STAA) shares shot up 26 percent to $21.03 after reporting upbeat Q1 results.
Shares of Integrated Media Technology Limited (NASDAQ: IMTE) got a boost, shooting up 56 percent to $34.2425. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
- [By Joseph Griffin]
STAAR Surgical (NASDAQ:STAA) was upgraded by equities researchers at TheStreet from a “c” rating to a “b-” rating in a research report issued on Monday.
- [By Lisa Levin] Gainers
Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
Ca - [By Lisa Levin]
STAAR Surgical Company (NASDAQ: STAA) shares shot up 28 percent to $21.40 after reporting upbeat Q1 results.
Shares of Integrated Media Technology Limited (NASDAQ: IMTE) got a boost, shooting up 57 percent to $34.52. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
- [By Lisa Levin] Gainers
Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90.
Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00.
Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday.
STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results.
Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday.
Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share.
YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings.
ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15.
MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings.
Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings.
TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results.
Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings.
TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results.
Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings.
Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results.
Logitech International S.A. (NASDAQ: LOGI)
Best Medical Stocks To Own Right Now: Waste Management, Inc.(WM)
Advisors’ Opinion:
- [By ]
For his “Executive Decision” segment, Cramer spoke with Jim Fish, president and CEO of Waste Management (WM) , which just posted an eight-cents-a-share earnings beat, but saw shares decline as investors worry over the impact of trade wars with China on the company’s recycling business.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Waste Management (WM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
KAMES CAPITAL plc grew its stake in shares of Waste Management (NYSE:WM) by 26.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 25,022 shares of the business services provider’s stock after buying an additional 5,215 shares during the period. KAMES CAPITAL plc’s holdings in Waste Management were worth $2,105,000 as of its most recent filing with the Securities and Exchange Commission.
Best Medical Stocks To Own Right Now: Accenture plc.(ACN)
Advisors’ Opinion:
- [By ]
But the segment revenue figures make it clear that momentum in areas such as cloud apps/services and security is being offset by pressures within older, non-cloud, software and services businesses in fields such as databases, operating systems, consulting, tech support and business process outsourcing (BPO). And that when one combines the good and the bad, the end-result is a company whose forex-adjusted growth remains noticeably below that of peers such as Microsoft (MSFT) , Accenture (ACN) , SAP (SAP) and Dell Technologies, and for which growing FCF remains a challenge.
- [By Logan Wallace]
Smith Asset Management Group LP lifted its position in shares of Accenture (NYSE:ACN) by 2.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 67,628 shares of the information technology services provider’s stock after acquiring an additional 1,398 shares during the quarter. Smith Asset Management Group LP’s holdings in Accenture were worth $10,381,000 at the end of the most recent quarter.
- [By Steve Symington, Maxx Chatsko, and Brian Feroldi]
To that end, we asked three top Motley Fool contributors to each pick a stock they think you would be wise to purchase and hold for the next 50 years. Read on to see why they like Corning (NYSE:GLW), Accenture (NYSE:ACN), and A.O. Smith (NYSE:AOS).
- [By Wayne Duggan]
From an investing standpoint, Foresi said IT Services stocks such as IBM (NYSE: IBM), Accenture Plc (NYSE: ACN) and Cognizant Technology Solutions Corp (NASDAQ: CTSH) could benefit from a rise in blockchain projects.
- [By Max Byerly]
Shares of Accenture Plc (NYSE:ACN) have been assigned a consensus recommendation of “Buy” from the twenty-seven ratings firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and fourteen have assigned a buy rating to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $160.70.
- [By Money Morning News Team]
The companies that participated in the demo included Cisco Systems Inc. (Nasdaq: CSCO), Microsoft Corp. (Nasdaq: MSFT), Accenture Plc. (NYSE: ACN), Fujitsu Ltd. (OTCMKTS: FJTSY), and Deutsche Telekom AG (OTCMKTS: DTEGY).
